(Q33504283)
Statements
Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma (English)
Mulligan T
Carrasquillo JA
Chung Y
Milenic DE
Schlom J
Feuerstein I
Paik C
Perentesis P
Reynolds J
1 December 1995